Unknown

Dataset Information

0

A Cell-Penetrating Peptide Modified Cu2-xSe/Au Nanohybrid with Enhanced Efficacy for Combined Radio-Photothermal Therapy.


ABSTRACT: Radiotherapy (RT) is one of the main clinical therapeutic strategies against cancer. Currently, multiple radiosensitizers aimed at enhancing X-ray absorption in cancer tissues have been developed, while limitations still exist for their further applications, such as poor cellular uptake, hypoxia-induced radioresistance, and unavoidable damage to adjacent normal body tissues. In order to address these problems, a cell-penetrating TAT peptide (YGRKKRRQRRRC)-modified nanohybrid was constructed by doping high-Z element Au in hollow semiconductor Cu2-xSe nanoparticles for combined RT and photothermal therapy (PTT) against breast cancer. The obtained Cu2-xSe nanoparticles possessed excellent radiosensitizing properties based on their particular band structures, and high photothermal conversion efficiency beneficial for tumor ablation and promoting RT efficacy. Further doping high-Z element Au deposited more high-energy radiation for better radiosensitizing performance. Conjugation of TAT peptides outside the constructed Cu2-xSe/Au nanoparticles facilitated their cellular uptake, thus reducing overdosage-induced side effects. This prepared multifunctional nanohybrid showed powerful suppression effects towards breast cancer, both in vitro and in vivo via integrating enhanced cell penetration and uptake, and combined RT/PTT strategies.

SUBMITTER: Ran R 

PROVIDER: S-EPMC9823383 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

A Cell-Penetrating Peptide Modified Cu<sub>2-x</sub>Se/Au Nanohybrid with Enhanced Efficacy for Combined Radio-Photothermal Therapy.

Ran Ruixue R   Guo Sinan S   Jiang Xiaoyu X   Qian Zhanyin Z   Guo Zhaoyang Z   Wang Yinsong Y   Cao Mingxin M   Yang Xiaoying X  

Molecules (Basel, Switzerland) 20230103 1


Radiotherapy (RT) is one of the main clinical therapeutic strategies against cancer. Currently, multiple radiosensitizers aimed at enhancing X-ray absorption in cancer tissues have been developed, while limitations still exist for their further applications, such as poor cellular uptake, hypoxia-induced radioresistance, and unavoidable damage to adjacent normal body tissues. In order to address these problems, a cell-penetrating TAT peptide (YGRKKRRQRRRC)-modified nanohybrid was constructed by d  ...[more]

Similar Datasets

| S-EPMC8650506 | biostudies-literature
| S-EPMC10255549 | biostudies-literature
| S-EPMC9505850 | biostudies-literature
| S-EPMC4132849 | biostudies-other
| S-EPMC8664818 | biostudies-literature
| S-EPMC8543882 | biostudies-literature
| S-EPMC5115396 | biostudies-literature
| S-EPMC6325113 | biostudies-literature
| S-EPMC4838545 | biostudies-literature
| S-EPMC9587984 | biostudies-literature